Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
21.06
+0.31 (1.49%)
At close: Nov 4, 2026, 4:00 PM EST
21.99
+0.93 (4.42%)
After-hours: Nov 4, 2026, 7:58 PM EST
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Takeda Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $23. The average 1-year stock price forecast is 9.21% higher than the current stock price, while the lowest is $20.97 (-0.43%) and the highest is $25.97 (+23.31%).
Price Target: $23 (+9.21%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 14, 2026.
Analyst Ratings
The average analyst rating for Takeda Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $43 | Buy | Maintains | $43 | +104.62% | Sep 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $21 | Buy | Maintains | $21 | -0.28% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
4.71T
from 4.51T
Increased by 4.46%
Revenue Next Year
4.81T
from 4.71T
Increased by 2.11%
EPS This Year
138.19
from -96.75
EPS Next Year
201.19
from 138.19
Increased by 45.59%
Financial currency is JPY.